Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
South Africa
0
Listed Dossiers
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Pasireotide Embonate
2. Som230 Pamoate
3. Som-230 Pamoate
4. Pasireotide (pamoate)
5. Signifor Lar
6. 396091-79-5 (pamoate)
7. 396091-79-5
8. 04f55a7uz3
9. Cyclo((2s)-2-phenylglycyl-d-tryptophyl-l-lysyl-o-(phenylmethyl)-l-tyrosyl-l-phenylalanyl-(4r)-4-((((2-aminoethyl)amino)carbonyl)oxy)-l-prolyl), 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate) (1:1)
10. (3s,6r,9s,12s,15s,19r,20as)-6-((1h-indol-3-yl)methyl)-9-(4-aminobutyl)-15-benzyl-12-(4-(benzyloxy)benzyl)-1,4,7,10,13,16-hexaoxo-3-phenylicosahydropyrrolo[1,2-a][1,4,7,10,13,16]hexaazacyclooctadecin-19-yl (2-aminoethyl)carbamate 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate)
11. Pasireotide Pamoate [jan]
12. Unii-04f55a7uz3
13. Pasireotide Embonate [who-dd]
14. Pasireotide Pamoate [orange Book]
15. Hy-108768
16. Cs-0031013
17. Q27247644
18. [(3s,6s,9s,12r,15s,18s,20r)-9-(4-aminobutyl)-3-benzyl-12-(1h-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate;4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid
Molecular Weight | 1435.6 g/mol |
---|---|
Molecular Formula | C81H82N10O15 |
Hydrogen Bond Donor Count | 13 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 22 |
Exact Mass | 1434.59611195 g/mol |
Monoisotopic Mass | 1434.59611195 g/mol |
Topological Polar Surface Area | 396 Ų |
Heavy Atom Count | 106 |
Formal Charge | 0 |
Complexity | 2510 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
DRUG PRODUCT COMPOSITIONS
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
85
PharmaCompass offers a list of Pasireotide Pamoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pasireotide Pamoate manufacturer or Pasireotide Pamoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pasireotide Pamoate manufacturer or Pasireotide Pamoate supplier.
PharmaCompass also assists you with knowing the Pasireotide Pamoate API Price utilized in the formulation of products. Pasireotide Pamoate API Price is not always fixed or binding as the Pasireotide Pamoate Price is obtained through a variety of data sources. The Pasireotide Pamoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 04F55A7UZ3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 04F55A7UZ3, including repackagers and relabelers. The FDA regulates 04F55A7UZ3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 04F55A7UZ3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 04F55A7UZ3 supplier is an individual or a company that provides 04F55A7UZ3 active pharmaceutical ingredient (API) or 04F55A7UZ3 finished formulations upon request. The 04F55A7UZ3 suppliers may include 04F55A7UZ3 API manufacturers, exporters, distributors and traders.
04F55A7UZ3 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 04F55A7UZ3 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 04F55A7UZ3 GMP manufacturer or 04F55A7UZ3 GMP API supplier for your needs.
A 04F55A7UZ3 CoA (Certificate of Analysis) is a formal document that attests to 04F55A7UZ3's compliance with 04F55A7UZ3 specifications and serves as a tool for batch-level quality control.
04F55A7UZ3 CoA mostly includes findings from lab analyses of a specific batch. For each 04F55A7UZ3 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
04F55A7UZ3 may be tested according to a variety of international standards, such as European Pharmacopoeia (04F55A7UZ3 EP), 04F55A7UZ3 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (04F55A7UZ3 USP).